459 related articles for article (PubMed ID: 30760241)
1. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.
van der Flier FE; Kwee CMB; Cath DC; Batelaan NM; Groenink L; Duits P; van der Veen DC; van Balkom AJLM; Baas JMP
BMC Psychiatry; 2019 Feb; 19(1):69. PubMed ID: 30760241
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial.
Kwee CM; Baas JM; van der Flier FE; Groenink L; Duits P; Eikelenboom M; van der Veen DC; Moerbeek M; Batelaan NM; van Balkom AJ; Cath DC
Eur Neuropsychopharmacol; 2022 Jun; 59():58-67. PubMed ID: 35561538
[TBL] [Abstract][Full Text] [Related]
3. Short-term effectiveness of web-based guided self-help for phobic outpatients: randomized controlled trial.
Kok RN; van Straten A; Beekman AT; Cuijpers P
J Med Internet Res; 2014 Sep; 16(9):e226. PubMed ID: 25266929
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost-effectiveness of web-based treatment for phobic outpatients on a waiting list for psychotherapy: protocol of a randomised controlled trial.
Kok RN; van Straten A; Beekman A; Bosmans J; de Neef M; Cuijpers P
BMC Psychiatry; 2012 Aug; 12():131. PubMed ID: 22937959
[TBL] [Abstract][Full Text] [Related]
5. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N
BMC Psychiatry; 2024 Mar; 24(1):175. PubMed ID: 38433233
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
7. No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.
Hofmeijer-Sevink MK; Duits P; Rijkeboer MM; Hoogendoorn AW; van Megen HJ; Vulink NC; Denys DA; van den Hout MA; van Balkom AJ; Cath DC
J Clin Psychopharmacol; 2017 Oct; 37(5):531-539. PubMed ID: 28820746
[TBL] [Abstract][Full Text] [Related]
8. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
[TBL] [Abstract][Full Text] [Related]
9. Post-exposure cortisol administration does not augment the success of exposure therapy: A randomized placebo-controlled study.
Raeder F; Merz CJ; Tegenthoff M; Wolf OT; Margraf J; Zlomuzica A
Psychoneuroendocrinology; 2019 Jan; 99():174-182. PubMed ID: 30245330
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids enhance in vivo exposure-based therapy of spider phobia.
Soravia LM; Heinrichs M; Winzeler L; Fisler M; Schmitt W; Horn H; Dierks T; Strik W; Hofmann SG; de Quervain DJ
Depress Anxiety; 2014 May; 31(5):429-35. PubMed ID: 24265104
[TBL] [Abstract][Full Text] [Related]
11. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N;
BMC Psychiatry; 2018 May; 18(1):140. PubMed ID: 29776349
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM; Queiroz RH; Chagas MH; de Oliveira DC; De Martinis BS; Kapczinski F; Quevedo J; Roesler R; Schröder N; Nardi AE; Martín-Santos R; Hallak JE; Zuardi AW; Crippa JA
Neuropsychopharmacology; 2011 May; 36(6):1219-26. PubMed ID: 21307846
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series.
Elms L; Shannon S; Hughes S; Lewis N
J Altern Complement Med; 2019 Apr; 25(4):392-397. PubMed ID: 30543451
[TBL] [Abstract][Full Text] [Related]
14. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
15. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
[TBL] [Abstract][Full Text] [Related]
16. Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction.
Kwee CMB; van der Flier FE; Duits P; van Balkom AJLM; Cath DC; Baas JMP
Psychopharmacology (Berl); 2024 Apr; 241(4):833-847. PubMed ID: 38044339
[TBL] [Abstract][Full Text] [Related]
17. Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial.
Telch MJ; Fischer CM; Zaizar ED; Rubin M; Papini S
Contemp Clin Trials; 2022 Nov; 122():106933. PubMed ID: 36154908
[TBL] [Abstract][Full Text] [Related]
18. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
[TBL] [Abstract][Full Text] [Related]
19. Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).
Mersiades AJ; Tognela A; Haber PS; Stockler M; Lintzeris N; Simes J; McGregor I; Olver I; Allsop DJ; Gedye C; Kirby AC; Morton RL; Fox P; Clarke S; Briscoe K; Aghmesheh M; Wong N; Walsh A; Hahn C; Grimison P
BMJ Open; 2018 Sep; 8(9):e020745. PubMed ID: 30209152
[TBL] [Abstract][Full Text] [Related]
20. [Treating specific childhood phobia in a single session? A systematic review of the literature].
Fond G; Franc N
Encephale; 2013 Apr; 39(2):109-14. PubMed ID: 23095586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
